Literature DB >> 17972006

Increasing evidence for the safety and efficacy of alcohol septal ablation during medium- and long-term follow-up.

M Pauschinger, A Keren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17972006     DOI： 10.1007/s00392-007-0580-2

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  36 in total

1.  The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization.

Authors:  J Schulz-Menger; O Strohm; J Waigand; F Uhlich; R Dietz; M G Friedrich
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

Review 2.  Clinical practice. Hypertrophic obstructive cardiomyopathy.

Authors:  Rick A Nishimura; David R Holmes
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

3.  Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.

Authors:  Perry M Elliott; Juan R Gimeno; María T Tomé; Jaymin Shah; Deirdre Ward; Rajesh Thaman; Jens Mogensen; William J McKenna
Journal:  Eur Heart J       Date:  2006-06-05       Impact factor: 29.983

4.  Ventricular tachycardia complicating alcohol septal ablation.

Authors:  Chester M Boltwood; Walter Chien; Thomas Ports
Journal:  N Engl J Med       Date:  2004-10-28       Impact factor: 91.245

5.  Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Steve R Ommen; Barry J Maron; Iacopo Olivotto; Martin S Maron; Franco Cecchi; Sandro Betocchi; Bernard J Gersh; Michael J Ackerman; Robert B McCully; Joseph A Dearani; Hartzell V Schaff; Gordon K Danielson; A Jamil Tajik; Rick A Nishimura
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

6.  Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy.

Authors:  Thorsten Lawrenz; Ludger Obergassel; Frank Lieder; Christian Leuner; Claudia Strunk-Mueller; Dorothee Meyer Zu Vilsendorf; Gerald Beer; Horst Kuhn
Journal:  Pacing Clin Electrophysiol       Date:  2005-04       Impact factor: 1.976

7.  Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.

Authors:  Uma S Valeti; Rick A Nishimura; David R Holmes; Philip A Araoz; James F Glockner; Jerome F Breen; Steve R Ommen; Bernard J Gersh; A Jamil Tajik; Charanjit S Rihal; Hartzell V Schaff; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2007-01-04       Impact factor: 24.094

8.  Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes.

Authors:  S Firoozi; P M Elliott; S Sharma; A Murday; S J Brecker; M S Hamid; B Sachdev; R Thaman; W J McKenna
Journal:  Eur Heart J       Date:  2002-10       Impact factor: 29.983

9.  Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.

Authors:  Su Min Chang; Nasser M Lakkis; Jennifer Franklin; William H Spencer; Sherif F Nagueh
Journal:  Circulation       Date:  2004-02-16       Impact factor: 29.690

10.  Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry.

Authors:  H Kuhn; H Seggewiss; F H Gietzen; P Boekstegers; L Neuhaus; L Seipel
Journal:  Z Kardiol       Date:  2004-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.